Investigation of Antiphosphatidyl-Serine Antibody and Antiphosphatidyl-Inositol Antibody in Ischemic Stroke Patients

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td align="left">Case</td><td align="center">Age/Gender</td><td align="center"><i>β</i>2-GPI aCL</td><td align="center">IgG-aCL</td><td align="center">LA</td><td align="center">PI</td><td align="center">PS</td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td align="left">1</td><td align="center">50 M</td><td align="center">+</td><td align="center">−</td><td align="center">+</td><td align="center">−</td><td align="center">+</td></tr><tr><td align="left">2</td><td align="center">41 F</td><td align="center">+</td><td align="center">−</td><td align="center">+</td><td align="center">−</td><td align="center">−</td></tr><tr><td align="left">3</td><td align="center">29 F</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">−</td><td align="center">−</td></tr><tr><td align="left">4</td><td align="center">31 F</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td></tr><tr><td align="left">5</td><td align="center">46 F</td><td align="center">−</td><td align="center">−</td><td align="center">−</td><td align="center">+</td><td align="center">+</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Antiphospholipid-protein antibodies in stroke patients with SLE.

Journal of Immunology Research

tab1

Table 1

Table 1: Investigation of Antiphosphatidyl-Serine Antibody and Antiphosphatidyl-Inositol Antibody in Ischemic Stroke Patients 